Long-term outcomes of patients investigated for suspected upper extremities deep venous thrombosis irrespective of imaging results
Background Outcome data are limited for upper extremity deep venous thrombosis (UEDVT).
Background Outcome data are limited for upper extremity deep venous thrombosis (UEDVT).
Background: Venous thromboembolism (VTE) prophylaxis is effective in the prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE) in medical patients.
Methods: A retrospective chart review was performed on medical inpatients at two academic hospitals in Hamilton, Ontario to investigate if patients received VTE prophylaxis as per current guidelines.
For the first time in 50 years new oral anticoagulants of proven efficacy and with acceptable safety profiles are available for patients with atrial fibrillation and venous thromboembolism. Here is a brief overview of the benefits and possible disadvantages of using these drugs.
KEYWORDS Dabigatran, rivaroxaban, apixaban, anticoagulation, atrial fibrillation, venous thromboembolism
DECLARATIONS OF INTERESTS No conflicts of interest declared.
Background: Venous thromboembolism (VTE) prophylaxis is effective in the prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE) in medical patients.
Methods: A retrospective chart review was performed on medical inpatients at two academic hospitals in Hamilton, Ontario to investigate if patients received VTE prophylaxis as per current guidelines.